Loading...
Bortezomib Reinduction Chemotherapy in High-Risk ALL in First Relapse: A Report from the Children’s Oncology Group
While survival in paediatric acute lymphoblastic leukaemia (ALL) is excellent, survival following relapse is poor. Previous studies suggest proteasome inhibition with chemotherapy improves relapse ALL response rates. This phase 2 Children’s Oncology Group study tested the hypothesis that adding the...
Na minha lista:
| Udgivet i: | Br J Haematol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6606340/ https://ncbi.nlm.nih.gov/pubmed/30957229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15919 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|